Acacia Pharma

Scroll
Investment area
Novo Ventures
Region
Europe
Date of investment
August 2013
Website
http://www.acaciapharma.com/

Acacia Pharma is focused on the development of compounds for the prevention and treatment of nausea and vomiting following surgery and chemotherapy. The lead programme is in phase 3 clinical development.

Novo Holdings uses cookies to ensure that we give you the best experience on our website. Read more